Mammalian target of rapamycin, insulin resistance and hidradenitis suppurativa: a possible metabolic loop

E-ISSN： 1468-3083|30|9|1631-1633

ISSN： 0926-9959

Source： JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol.30, Iss.9, 2016-09, pp. : 1631-1633

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Development of resistance to Mycobacterium tuberculosis is manageable in hidradenitis suppurativa. Response to ‘Treatment of hidradenitis suppurativa with rifampicin: have we forgotten tuberculosis?’

BRITISH JOURNAL OF DERMATOLOGY, Vol. 178, Iss. 1, 2018-01 ,pp. : 300-300

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mammalian Target of Rapamycin Inhibitors Resistance Mechanisms in Clear Cell Renal Cell Carcinoma

Current Signal Transduction Therapy, Vol. 8, Iss. 3, 2013-01 ,pp. : 210-218

Bentham Science Publishers

Access to resources Recommend Favorite

Atypical hidradenitis suppurativa

CLINICAL & EXPERIMENTAL DERMATOLOGY, Vol. 40, Iss. 8, 2015-12 ,pp. : 891-893

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mammalian Target of Rapamycin as a Rational Therapeutic Target for Breast Cancer Treatment

Oncology, Vol. 84, Iss. 1, 2012-10 ,pp. : 43-56

Karger

Access to resources Recommend Favorite

The bacteriology of hidradenitis suppurativa: a systematic review

EXPERIMENTAL DERMATOLOGY (ELECTRONIC), Vol. 906-6705, Iss. 10, 2015-10 ,pp. : 727-731

John Wiley & Sons Inc

Access to resources Recommend Favorite